Affluent Medical S.A.
AFME.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €1 | €4 | €1 | €1 |
| % Growth | -86% | 523% | 4.3% | – |
| Cost of Goods Sold | €2 | €12 | €1 | €1 |
| Gross Profit | -€1 | -€3 | -€0 | -€1 |
| % Margin | -197.9% | -80.2% | -66.6% | -96.7% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €6 | €7 | €6 |
| SG&A Expenses | €7 | €7 | €7 | €6 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | -€4 | -€8 | €1 | €1 |
| Operating Expenses | €3 | -€2 | €8 | €7 |
| Operating Income | -€10 | -€6 | -€10 | -€8 |
| % Margin | -1,685.8% | -148.9% | -1,445.8% | -1,257.6% |
| Other Income/Exp. Net | -€0 | €0 | -€1 | -€1 |
| Pre-Tax Income | -€10 | -€6 | -€10 | -€9 |
| Tax Expense | -€1 | -€1 | -€1 | -€0 |
| Net Income | -€9 | -€5 | -€9 | -€8 |
| % Margin | -1,624.3% | -130.4% | -1,417.2% | -1,210.3% |
| EPS | -0.24 | -0.14 | -0.29 | -0.25 |
| % Growth | -71.4% | 51.7% | -16% | – |
| EPS Diluted | -0.24 | -0.14 | -0.29 | -0.25 |
| Weighted Avg Shares Out | 39 | 39 | 32 | 30 |
| Weighted Avg Shares Out Dil | 39 | 39 | 33 | 31 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €1 | -€0 | €1 | €0 |
| Depreciation & Amortization | €1 | €1 | €1 | €1 |
| EBITDA | -€8 | -€5 | -€8 | -€7 |
| % Margin | -1,404.9% | -125.7% | -1,250.5% | -1,095.4% |